A new type of MRI scan may distinguish active from chronic MS lesions without the need for injected contrast dye.

Two experimental drug molecules promoted myelin repair in MS disease models, pointing toward a possible future route for ...

Anti-CD20 therapies and S1P receptor modulators seem to be equally effective for most people with late-onset MS, a real-world ...

Most patients with early active relapsing-remitting MS treated with ocrelizumab did not see worse hand function or ambulation ...

Neuropathic pain is not your average pain. Here’s what to know about this unique type of MS pain and how to find relief. Pain is a common symptom of multiple sclerosis (MS), especially when the spinal ...

Here we describe the use of CAR T therapy to treat multiple sclerosis in mice. Previous installments discuss the fundamentals of CAR T and its applications for B cell cancers, multiple myeloma, lupus, ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...

Grace Miller was a 24-year-old law school student when she was diagnosed with multiple sclerosis. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content.

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and safety in diverse patient populations. The MUSETTE trial confirmed that the ...

In the human brain, neurofilament light chain (NfL, shown in brown) is seen in brain cells and the neural wires that connect them. UCSF researchers found NfL in the bloodstream of patients who would ...

Share on Pinterest Subtle signs of multiple sclerosis may appear more than a decade before onset, recent research suggests. Image credit: Pancake Pictures/Getty Images Research is ongoing regarding ...